These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1512070)

  • 1. Effects of MPTP and vitamin E treatments on immune function in mice.
    Chi DS; Gong L; Daigneault EA; Kostrzewa RM
    Int J Immunopharmacol; 1992 Jul; 14(5):739-46. PubMed ID: 1512070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E supplements fail to protect mice from acute MPTP neurotoxicity.
    Gong L; Daigneault EA; Acuff RV; Kostrzewa RM
    Neuroreport; 1991 Sep; 2(9):544-6. PubMed ID: 1751810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations.
    Mihatsch W; Russ H; Gerlach M; Riederer P; Przuntek H
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):73-8. PubMed ID: 1905937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Dluzen D; Jain R; Liu B
    J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological changes in the MPTP-induced Parkinson's disease mouse model.
    Bieganowska K; Członkowska A; Bidziński A; Mierzewska H; Korlak J
    J Neuroimmunol; 1993 Jan; 42(1):33-7. PubMed ID: 8423206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.
    Beal MF; Matthews RT; Tieleman A; Shults CW
    Brain Res; 1998 Feb; 783(1):109-14. PubMed ID: 9479058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
    J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Martinovits G; Melamed E; Cohen O; Rosenthal J; Uzzan A
    Neurosci Lett; 1986 Aug; 69(2):192-7. PubMed ID: 3489911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Melamed E; Rosenthal J; Youdim MB
    J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term feeding of high vitamin E diet improves the decreased mitogen response of rat splenic lymphocytes with aging.
    Sakai S; Moriguchi S
    J Nutr Sci Vitaminol (Tokyo); 1997 Feb; 43(1):113-22. PubMed ID: 9151245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U; Ramsay KA; Jiang H; Jackson-Lewis V; Donaldson D; Fernando S; Ferreira M; Przedborski S
    Exp Neurol; 1994 Apr; 126(2):195-204. PubMed ID: 7925820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
    Chan P; Di Monte DA; Langston JW; Janson AM
    J Pharmacol Exp Ther; 1997 Jan; 280(1):439-46. PubMed ID: 8996226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.
    Perry TL; Yong VW; Clavier RM; Jones K; Wright JM; Foulks JG; Wall RA
    Neurosci Lett; 1985 Sep; 60(2):109-14. PubMed ID: 3877260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice.
    Chen CM; Yin MC; Hsu CC; Liu TC
    Nutrition; 2007; 23(7-8):589-97. PubMed ID: 17574387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice.
    Dluzen DE; Kefalas G
    Brain Res; 1996 Nov; 741(1-2):215-9. PubMed ID: 9001725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
    Götz ME; Dirr A; Burger R; Janetzky B; Weinmüller M; Chan WW; Chen SC; Reichmann H; Rausch WD; Riederer P
    Eur J Pharmacol; 1994 Feb; 266(3):291-300. PubMed ID: 8174612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
    Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
    J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
    Spooren WP; Vassout A; Waldmeier P; Gentsch C
    Eur J Pharmacol; 1998 Jul; 353(1):1-4. PubMed ID: 9721033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
    Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.